Von Willebrand factor and soluble E-selectin in hypertension: Influence of treatment and value in predicting the progression of atherosclerosis

Coronary Artery Disease

Volumn 7, Issue 2, 1996, Pages 143-147

  Blann, Andrew D ^a   Waite, Malcolm A ^b  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b SELLY OAK HOSPITAL   (United Kingdom)

Author keywords

atherosclerosis; endothelium; hypertension; soluble E selectin; von Willebrand factor

Indexed keywords

CHOLESTEROL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; THIOCYANATE; VON WILLEBRAND FACTOR;

ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STROKE; SYSTOLIC BLOOD PRESSURE;

EID: 0030054995     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199602000-00008     Document Type: Article

References (25)

1. Chobanian AV: Vascular effects of systemic hypertension. Am J Coll Cardiol 1992, 69:3E-7E.
2. Blann AD, Naqvi T, Waite M, McCollum CN: von Willebrand factor and endothelial damage in hypertension. J Hum Hypertens 1993, 7:107-111.
3. Blann AD: von Willebrand factor and the endothelium in vascular disease. Br J Biomed Sci 1993, 50:125-134.
4. Panza JA, Quyumi AA, Brush JE, Epstein SE: Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. New Engl J Med 1990, 323:22-27.
5. Newman W, Beall LD, Carson CW, Hunder GC, Graben N, Randhawa ZI, et al.: Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J Immunol 1993, 150:644-654.
6. Blann AD, Tse W, Maxwell SRJ, Waite MA: Increased levels of soluble adhesion molecules E-selectin in essential hypertension. J Hypertens 1994, 12:925-928.
7. Watts GF, Lewis B, Brunt JHN, Lewis ES, Coltart DJ, Smith LDR, et al.: Effects on coronary artery disease of lipid lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet 1992, 339:563-569.
8. Collins R, Peto R, MacMahon S, Hebert P, Fieback NH, Eberlein KA, et al.: Blood pressure, stroke, and coronary heart disease. Lancet 1990, 335:827-838.
9. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809.
10. Blann AD, McCollum CN: Adverse influence of cigarette smoking on the endothelium. Thromb Haemost 1993, 70:707-711
11. Blann AD, Bushell D, Davies A, Faragher EB, Miller JP, McCollum CN: von Willebrand factor, the endothelium and obesity, Int J Obesity 1993, 17:723-725.
12. Blann AD, Jackson P, Bath PMW, Watts GF: Associations between nutrient intake and serum von Willebrand factor in patients with coronary artery disease. J Int Med 1995, 237:557-561.
13. Jonasson J-H, Hilsson TK, Johnson O: von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J 1991, 66:351-355.
14. Rose GA: The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull WHO 1962, 27:654-658.
15. Green D, Kucuk O, Haring O, Dyer A: The factor VIII complex in atherosclerosis: effects of aspirin. J Chron Dis 1981, 34:21-26.
16. Pearson JD: Markers of endothelial perturbation and damage. Br J Rheum 1993, 32:651-652.
17. Gralnick HR: von Willebrand's disease. In Disorders of Haemostasis. Edited by Ratnotf OD, Forbes CD. Philadelphia: Saunders; 1991:203-244.
18. Blann AD, McCollum CN: Increased levels of soluble adhesion molecules in atherosclerosis. Thromb Haemost 1994, 72:151-154.
19. Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ: Angiogensis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 1995, 376:517-519.
20. Fowkes FGR, Lowe GDO, Housley E, Rattray A, Rumley A, Elton RA, et al.: Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet 1993, 342:84-86.
21. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW: Haemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. New Engl J Med 1995, 332:635-641.
22. Meade TW, Cooper JA, Stirling Y, Howarth DJ, Ruddock V, Miller GJ: Factor VIII, ABO blood group and the incidence of ischaemic heart disease. Br J Haem 1994, 88:601-607.
23. Alexander RW: Hypertension and the pathogenesis of atherosclerosis. Hypertension 1995, 25:155-161.
24. Egashira K, Inou T, Hirooka Y, Yamade A, Urabe Y, Takeshita A: Evidence of impaired endothelium dependent coronary vasodilation in patients with angina pectoris and normal coronary angiograms, New Engl J Med 1993, 328:1659-1664.
25. Meredith IT, Yeung AC, Weidinger FF, Anderson TJ, Uehata A, Ryan TJ, et al.: Role of Impaired endothellum-dependent vasodilation in ischaemic manifestations of coronary artery disease. Circ 1993, 87 (suppl V):56-66.